Arteriovenous CO2 removal improves survival compared to high frequency percussive and low tidal volume ventilation in a smoke/burn sheep acute respiratory distress syndrome model.
OBJECTIVES AND SUMMARY BACKGROUND: Low tidal volume ventilation (LTV) has improved survival with acute respiratory distress syndrome (ARDS) by reducing lung stretch associated with volutrauma and barotrauma. Additional strategies to reduce lung stretch include arteriovenous carbon dioxide removal (AVCO2R), and high frequency percussive ventilation (HFPV). We performed a prospective, randomized study comparing these techniques in our clinically relevant LD100 sheep model of ARDS to compare survival, pathology, and inflammation between the 3 ventilator methods.


METHODS
Adult sheep (n = 61) received smoke inhalation (48 breaths) and a 40% third-degree burn. After ARDS developed (Pao2/FiO2 <200), animals were randomized. In experiment 1, animals were killed at 48 hours after randomization. Hemodynamics, pulmonary function, injury scores, myeloperoxidase (MPO) in lung tissues and neutrophils, IL-8 in lung tissues, and apoptosis were evaluated. In experiment 2, the end point was survival to 72 hours after onset of ARDS or end-of-life criteria with extension of the same studies performed in experiment 1.


RESULTS
There were no differences in hemodynamics, but minute ventilation was lower in the AVCO2R group and Paco2 for the HFPV and AVCO2R animals remained lower than LTV. Airway obstruction and injury scores were not different among the 3 ventilation strategies. In experiment 1, lung tissue MPO and IL-8 were not different among the ventilation strategies. However, in experiment 2, lung tissue MPO was significantly lower for AVCO2R-treated animals (AVCO2R < HFPV < LTV). TUNEL staining showed little DNA breakage in neutrophils from experiment 1, but significantly increased breakage in all 3 ventilator strategies in experiment 2. In contrast, AVCO2R tissue neutrophils showed significant apoptosis at 72 hours post-ARDS criteria as measured by nuclear condensation (P < 0.001). Survival 72 hours post-ARDS criteria was highest for AVCO2R (71%) compared with HFPV (55%) and LTV (33%) (AVCO2R vs. LTV, P = 0.05).


CONCLUSIONS
Significantly more animals survived AVCO2R than LTV. In experiment 2, Lung MPO was significantly lower for AVCO2R, compared with LTV (P < 0.05). This finding taken together with the TUNEL and neutrophil apoptosis results, suggested that disposition of neutrophils 72 hours post-ARDS criteria was different among the ventilatory strategies with neutrophils from AVCO2R-treated animals removed chiefly through apoptosis, but in the cases of HFPV and LTV, dying by necrosis in lung tissue.
Schmalstieg
Frank C
FC
Department of Pediatrics, University of Texas Medical Branch, Galveston, TX 77555, USA. fschmals@utmb.edu
Keeney
Susan E
SE
Rudloff
Helen E
HE
Palkowetz
Kimberly H
KH
Cevallos
Manuel
M
Zhou
Xiaoquin
X
Cox
Robert A
RA
Hawkins
Hal K
HK
Traber
Daniel L
DL
Zwischenberger
Joseph B
JB
D000704:Analysis of Variance; D000818:Animals; D017209:Apoptosis; D002059:Burns, Inhalation / Q000150:complications*; D002245:Carbon Dioxide / Q000097:blood*; D004195:Disease Models, Animal; D020287:In Situ Nick-End Labeling; D016209:Interleukin-8 / Q000378:metabolism; D011446:Prospective Studies; D011659:Pulmonary Gas Exchange; D011897:Random Allocation; D012121:Respiration, Artificial / Q000379:methods*; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000628:therapy*; D034561:Sheep, Domestic; D015208:Smoke Inhalation Injury / Q000150:complications*; D015996:Survival Rate; D013990:Tidal Volume
D016209:Interleukin-8; D002245:Carbon Dioxide
J Clin Invest. 1998 Feb 15;101(4):890-8
9466984
N Engl J Med. 1998 Feb 5;338(6):355-61
9449728
Am J Respir Crit Care Med. 1998 Dec;158(6):1831-8
9847275
J Burn Care Rehabil. 1999 May-Jun;20(3):232-5
10342478
Ann Thorac Surg. 1999 Jul;68(1):181-7
10421138
Chest. 1999 Jul;116(1 Suppl):89S-90S
10424608
Ann Surg. 1999 Aug;230(2):215-24
10450736
Perfusion. 1999 Jul;14(4):299-310
10456785
Crit Care Med. 1999 Aug;27(8):1492-8
10470755
Circ Res. 1965 May;16:482-8
14289157
Am J Respir Crit Care Med. 2005 Jan 15;171(2):147-57
15477499
J Biol Chem. 2005 Feb 18;280(7):5843-53
15576378
Crit Care Med. 2005 Mar;33(3 Suppl):S175-81
15753725
Crit Care Med. 2005 Mar;33(3 Suppl):S241-5
15753734
Crit Care Med. 2005 May;33(5):925-9
15891315
Am J Respir Crit Care Med. 2005 Jun 15;171(12):1371-7
15695495
N Engl J Med. 2006 Apr 27;354(17):1775-86
16641394
Blood. 2006 Oct 15;108(8):2821-6
16804110
Intensive Care Med. 1999 Sep;25(9):936-41
10501748
N Engl J Med. 2000 May 4;342(18):1301-8
10793162
Crit Care Med. 2000 May;28(5):1469-76
10834698
J Thorac Cardiovasc Surg. 2001 Mar;121(3):542-51
11241090
Am J Physiol Lung Cell Mol Physiol. 2001 Jun;280(6):L1233-41
11350803
ASAIO J. 2001 Jul-Aug;47(4):365-71
11482488
Intensive Care Med. 2001 Aug;27(8):1340-51
11511947
Burns. 2002 Aug;28(5):503-8
12163294
J Burn Care Rehabil. 2002 Nov-Dec;23(6):444-8
12432322
J Clin Invest. 2002 Dec;110(11):1703-16
12464676
Am J Respir Crit Care Med. 2003 Jan 15;167(2):171-9
12406830
Clin Sci (Lond). 2003 Mar;104(3):313-21
12605592
Am J Respir Cell Mol Biol. 2003 Sep;29(3 Pt 1):295-302
12936906
J Appl Physiol (1985). 2003 Oct;95(4):1385-93
12807894
N Engl J Med. 2004 Jul 22;351(4):327-36
15269312
J Biol Chem. 2004 Oct 22;279(43):44695-703
15292176
J Clin Invest. 1982 Apr;69(4):794-8
7076848
Am Rev Respir Dis. 1983 Mar;127(3):290-300
6830052
J Appl Physiol (1985). 1987 Jan;62(1):27-33
3558186
Surgery. 1988 Aug;104(2):208-15
3400056
Am Rev Respir Dis. 1988 Dec;138(6):1480-7
3144216
J Trauma. 1989 Mar;29(3):350-4
2926848
Intensive Care Med. 1990;16(6):372-7
2246418
Circ Shock. 1991 Jan;33(1):48-62
1849056
Arch Surg. 1993 Jul;128(7):772-8; discussion 778-80
8317959
Ann Surg. 1993 Sep;218(3):328-35; discussion 335-7
8373275
Chest. 1993 Dec;104(6):1833-59
8252973
Am J Respir Crit Care Med. 1994 Feb;149(2 Pt 1):311-9
7905767
J Appl Physiol (1985). 1994 Feb;76(2):539-44
8175560
Am J Respir Crit Care Med. 1994 Dec;150(6 Pt 1):1550-4
7952613
J Appl Physiol (1985). 1994 Sep;77(3):1355-65
7836140
J Burn Care Rehabil. 1997 Nov-Dec;18(6):531-4
9404988
Ann Thorac Surg. 1997 Dec;64(6):1599-604; discussion 1604-5
9436542
N Engl J Med. 1998 Feb 5;338(6):347-54
9449727
J Clin Invest. 1998 Jun 15;101(12):2900-9
9637725